계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
MetaFines
company
About
MetaFines is researching and developing anti-cancer drugs using cancer metabolism.
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ₩20B
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Oct 8, 2018
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
₩20B
MetaFines has raised a total of
₩20B
in funding over 2 rounds. Their latest funding was raised on
Apr 28, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 28, 2022 | Series B | ₩20B | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
MetaFines is funded by 3 investors.
Korea Investment Securities
and SNS-Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
